HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Michael Samson Selected Research

C Michael Samson Research Topics

Disease

5Uveitis
10/2015 - 11/2007
4Inflammation (Inflammations)
01/2015 - 09/2002
2Panuveitis
10/2015 - 08/2013
1Posterior Uveitis
03/2020
1Acute Retinal Necrosis Syndrome
03/2020
1Toxic Optic Neuropathy
01/2019
1Rheumatic Diseases (Rheumatism)
01/2019
1Autoimmune Diseases (Autoimmune Disease)
10/2015
1Retinal Detachment (Retinal Detachments)
10/2015
1Chikungunya Fever
01/2015
1Intermediate Uveitis (Chronic Cyclitis)
08/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2010
1Infections
10/2010
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2010
1Rheumatoid Arthritis
10/2010
1Experimental Arthritis
10/2010
1Macular Degeneration (Age-Related Maculopathy)
01/2009
1Choroidal Neovascularization
01/2009
1Multifocal Choroiditis
01/2009
1Spondylarthropathies
11/2007
1Macular Edema
09/2002
1Birdshot Chorioretinopathy
08/2002
1Eye Diseases (Eye Disease)
05/2002

Drug/Important Bio-Agent (IBA)

2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015 - 10/2010
2SteroidsIBA
08/2013 - 11/2007
1Retinaldehyde (Retinal)IBA
03/2020
1Quinacrine (Mepacrine)IBA
01/2019
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2019
1Antimalarials (Antimalarial Agents)IBA
01/2019
1VaccinesIBA
10/2015
1Fluorescein (Funduscein)FDA LinkGeneric
08/2013
1Interleukin-17 (Interleukin 17)IBA
10/2010
1secukinumabIBA
10/2010
1Bevacizumab (Avastin)FDA Link
01/2009
1Ranibizumab (Lucentis)FDA Link
01/2009
1Immunologic Factors (Immunomodulators)IBA
11/2007
1Methotrexate (Mexate)FDA LinkGeneric
11/2007
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2007
1SiliconesIBA
09/2002
1Polymethyl Methacrylate (Sol)IBA
09/2002
1Heparin (Liquaemin)FDA LinkGeneric
09/2002
1Indicators and Reagents (Reagents)IBA
08/2002

Therapy/Procedure

3Therapeutics
03/2020 - 01/2015
1Immunomodulation
01/2015
1Lenses
09/2002
1Intraocular Lenses (Intraocular Lens)
09/2002
1Transplantation
05/2002